Key statistics
As of last trade Syndax Pharmaceuticals Inc (1T3:MUN) traded at 17.10, -25.65% below its 52-week high of 23.00, set on Jul 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.10 |
---|---|
High | 17.10 |
Low | 17.10 |
Bid | 16.50 |
Offer | 16.60 |
Previous close | 17.10 |
Average volume | 61.00 |
---|---|
Shares outstanding | 85.10m |
Free float | 83.53m |
P/E (TTM) | -- |
Market cap | 1.60bn USD |
EPS (TTM) | -3.38 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:03 BST.
More ▼
Press releases
- Foundation Medicine Partners with Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOne®Heme Platform
- Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)